Potential of lipoproteins as biomarkers in acute myocardial infarction

Area of Science:

• Cardiology
• Biochemistry
• Clinical Diagnostics

Background:

• Acute myocardial infarction (AMI), or heart attack, is a life-threatening emergency requiring prompt diagnosis and management.
• Current diagnosis relies on troponin T levels, but improved biomarkers for AMI diagnosis and prognosis are needed.
• Impaired lipid metabolism is linked to AMI development, highlighting lipoproteins as potential indicators.

Purpose of the Study:

• To review recent findings on the biomarker potential of various lipoproteins for AMI risk stratification.
• To assess lipoproteins as indicators of lipid metabolism relevant to AMI.
• To identify emerging biomarkers beyond troponin T for AMI.

Main Methods:

• Literature review of studies published between 2001 and 2016.
• Analysis of research on lipoprotein levels and their association with AMI.
• Synthesis of data on low-density lipoprotein, oxidized low-density lipoprotein, high-density lipoprotein, lipoprotein-a, and remnant lipoprotein.

Main Results:

• Lipoproteins are key components of lipid metabolism and serve as accessible blood biomarkers.
• Specific lipoproteins, including LDL, oxLDL, HDL, Lp(a), and remnant lipoproteins, show potential for AMI risk stratification.
• Findings suggest lipoproteins offer valuable insights into AMI pathophysiology and patient risk.

Conclusions:

• Lipoprotein profiling presents a promising avenue for enhancing AMI diagnosis and prognosis.
• Further research into lipoprotein signatures could lead to more accurate risk stratification tools.
• Biomarkers beyond troponin T are crucial for comprehensive AMI management.